You searched for "lesion"
Biomarkers reveal how patients with glaucoma may respond to treatment
Markers in the blood that predict whether glaucoma patients are at higher risk of continued loss of vision following conventional treatment have been identified by researchers at UCL and Moorfields Eye Hospital.GOSH (Great Ormond Street Hospital) Paediatric Ophthalmology Post-Graduate meeting - The Visiting Professors Day
Course Director: Prof Chris Lloyd, Consultant Ophthalmologist and Clinical Lead, Dept Ophthalmology, GOSH Event overview: The Visiting Professor's Day is a well-established GOSH Ophthalmology Unit tradition (dormant during the pandemic). It is all day postgraduate educational event aimed at those working with children with ophthalmic disorders including (but not exclusive to) Ophthalmologists, Orthoptists, Optometrists, Vision Scientists and academics. It will feature presentations from the GOSH ophthalmic and vision science team as well as talks from excellent external speakers including prominent "Visiting Professors" including Susmito Biswas (Cystinosis and the eye) Jane Ashworth (Advances in the ophthalmic management of the Mucopolysccharidoses) and Patrick Watts (Ophthalmic features of NAI; new RCOphth guidance).Surgitrac are pleased to announce that they have partnered with Surgi Lab CH to distribute their products in the UK.
Ophthalmic surgical procedures demand exceptional precision and dexterity. Not only do surgeons need to maintain hours of high level of focus and perform intricate movements, but they may need to switch between different instruments while performing a surgery.Modern practice options for UK ophthalmologists
When I spoke on setting up private practice at the annual United Kingdom & Ireland Society of Cataract & Refractive Surgeons (UKISCRS) meeting in November ’23 there was a lot of interest in different types of practice models. If we...Conference Report: Retina UK 2025
The Retina UK Annual Conference 2025 took place at the Holiday Inn London in London, UK, on 20 September and was hosted both in-person and online. The event included expert speakers, healthcare professionals, and patients with lived experience with retinal...Report: Kabgayi International Ophthalmology Conference 2024
My journey to Rwanda in April 2022 aimed to expand vitreoretinal services, but it also highlighted the need for robust scientific discourse, akin to the UK's ophthalmology culture, and so we seized the opportunity to plan an 'international' ophthalmology conference to coincide with a visit from five of my former UK consultant colleagues.Surgical strategies to manage incomitant strabismus in adults
Incomitant vertical and / or horizontal strabismus is a challenging presentation. Patients are usually symptomatic as the onset is either sudden so they haven’t developed any coping mechanisms or very complex so that any coping mechanisms will not cover all...Governments missing opportunity to increase economic progress
Report calls on governments to invest in eye health to address $410.9 billion loss in economic productivity.Optometry Today’s new education resource for practice teams
Optometry Today (OT) has released a new education package for optometry practice teams, delivered in partnership with the Association of Optometrists (AOP) and Johnson & Johnson Vision.
Unexplained vision loss following exposure to combat
Non-organic vision loss (NOVL) is defined as a decrease in visual acuity or visual field without an identifiable organic cause. NOVL can be particularly challenging and time-consuming to diagnose, especially where the vision loss is superimposed on an element of...
Aflibercept, bevacizumab or ranibizumab for diabetic macular oedema
Macular oedema (MO) is a leading cause of visual impairment in patients with diabetic retinopathy. Whilst laser photocoagulation therapy has been the proven treatment for decades, studies over the last five years have also established a role for anti-VEGF agents...
